Novavax, J&J Ink Covid-19 Vaccine Deals With U.K. for Tens of Millions of Doses
By Jonathan D. Rockoff and Jared S. Hopkins
U.K. will fund a late-stage trial of Novavax’s vaccine candidate, whle J&J agreed to provide 30 million doses
Novavax Inc. NVAX +11.39% and Johnson & Johnson JNJ +0.58% said Friday they have agreed to provide tens of millions of doses of their experimental coronavirus vaccines to the U.K. for undisclosed sums, as countries move to secure supplies of the shots.
Under the terms, the U.K. will fund a late-stage trial of Novavax’s vaccine candidate starting this quarter evaluating the shot in the country’s residents, and a contract manufacturer will make a key part of the vaccine at a plant in Stockton-on-Tees in…
View original post 355 more words